Lan Zhong

发表

STK31 as novel biomarker of metastatic potential and tumorigenicity of colorectal cancer

Junyi Han, E. Biskup, Wen Xu, 2017, Oncotarget.

A Dynamic Nomogram Predicting Portal Vein Thrombosis in Cirrhotic Patients During Primary Prophylaxis for Variceal Hemorrhage

Chang-qing Yang, Lan Zhong, Shuo Zhang, 2022, Frontiers in Medicine.

Model for end‐stage liver disease combined with serum prealbumin to predict the prognosis of patients with decompensated liver cirrhosis

Lan Zhong, Chi Chen, Fei Liu, 2010, Journal of digestive diseases.

A Novel Multiparameter Scoring Model for Noninvasive Early Prediction of Ischemic Colitis: A Multicenter, Retrospective, and Real-World Study

Junyi Han, Lan Zhong, Wei Wang, 2021, Clinical and translational gastroenterology.

Potential role of cyanidin 3-glucoside (C3G) in diabetic cardiomyopathy in diabetic rats: An in vivo approach

Hongli Li, Songwen Chen, Genqing Zhou, 2016, Saudi journal of biological sciences.

Combined MELD and blood lipid level in evaluating the prognosis of decompensated cirrhosis.

Wen Xu, Ming Jiang, Lan Zhong, 2010, World journal of gastroenterology.

Lentivirus-mediated knockdown of rhomboid domain containing 1 inhibits colorectal cancer cell growth.

Zhongmin Liu, Fei Liu, Junyi Han, 2015, Molecular medicine reports.

The Role of Bone Morphogenetic Protein 9 in Nonalcoholic Fatty Liver Disease in Mice

Lan Zhong, Wei Wang, Xin Zeng, 2021, Frontiers in Pharmacology.

IL36 indicating good prognosis in human Hepatocellular Carcinoma

Lan Zhong, Jie Tang, Y. Tong, 2020, Journal of Cancer.

Comparison of four models for end-stage liver disease in evaluating the prognosis of cirrhosis.

Ming Jiang, Lan Zhong, Fei Liu, 2008, World journal of gastroenterology.

Validation in China of a non‐invasive salivary pepsin biomarker containing two unique human pepsin monoclonal antibodies to diagnose gastroesophageal reflux disease

J. Zhong, X. Shen, Chang-qing Yang, 2019, Journal of digestive diseases.